NCT00913120View on ClinicalTrials.gov

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Venous Thromboembolism
Interventions
DRUG

YM150

oral

DRUG

Placebo

oral

DRUG

Enoxaparin

injection

Trial Locations (16)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyusyu

Shikoku

Tōhoku

Daegu

Jeonnam

Seoul

Changhua

Chiayi City

Taichung

Bangkok

Chiang Mai

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY